Carbetocin versus syntometrine for the third stage of labour following vaginal delivery—a double‐blind randomised controlled trial
Open Access
- 16 September 2009
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 116 (11) , 1461-1466
Abstract
Objective Prevention of postpartum haemorrhage is essential in the pursuit of improved health care for women. However, limited literature is available for comparing the use of oxytocin agonist carbetocin with syntometrine in women undergoing vaginal deliveries. We aimed to compare intramuscular carbetocin with intramuscular syntometrine for the routine prevention of postpartum haemorrhage in women who deliver vaginally.Design Prospective double‐blind randomised controlled trial.Setting Tertiary referral centre.Population Pregnant women with no contraindication for vaginal delivery recruited from January 2005 to April 2008.Methods Participants were randomised to receive either syntometrine or carbetocin during the third stage of labour.Main outcome measures Primary outcome measure was postpartum haemorrhage requiring additional uterotonics. Secondary outcome measures were the incidence of postpartum haemorrhage (≥500 ml), severe postpartum haemorrhage (≥1000 ml) and adverse effects profile.Results Women in the carbetocin group (13.5%) and in the syntometrine group (16.8%) had postpartum haemorrhage requiring additional uterotonics (P = 0.384). 1.6% of women in each group had postpartum haemorrhage (P = 1.0) and the estimated blood loss during the third stage of labour was similar between the two groups (P = 0.294). Women who had syntometrine were four times more likely to experience nausea (RR = 4.2; 95% CI 2.2–7.8) and vomiting (RR = 4.3; 95% CI 1.9–9.5) compared with women who had carbetocin. Tremor, sweating, retching and uterine pain were also more likely in the syntometrine group compared with the carbetocin group (P < 0.05).Conclusions Carbetocin has an efficacy similar to syntometrine for prevention of postpartum haemorrhage, but is associated with less adverse effects.Keywords
This publication has 17 references indexed in Scilit:
- Oxytocin agonists for preventing postpartum haemorrhage2007
- Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggerationActa Obstetricia et Gynecologica Scandinavica, 2006
- The postpartum period: the key to maternal mortalityInternational Journal of Gynecology & Obstetrics, 1996
- A Comparison Between Visual Estimation and Laboratory Detennination of Blood Loss During the Third Stage of LabourAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1996
- A randomised double blind comparison of Syntometrine® and Syntocinon® in the management of the third stage of labourBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour.BMJ, 1993
- Adverse cardiovascular sequelae of ergometrineBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterusClinical Pharmacology & Therapeutics, 1992
- Discrepancy between laboratory determination and visual estimation of blood loss during normal deliveryEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- A reappraisal of the use of ergometrineJournal of Obstetrics and Gynaecology, 1981